Literature DB >> 21671993

Approach to reticulate hyperpigmentation.

V Vachiramon1.   

Abstract

Reticulate hyperpigmentation is a feature of a number of conditions, which differ in age of onset and distribution of the lesions. Associated clinical findings (e.g. hair, nail, teeth, systemic involvement), are used to differentiate between the conditions. Histopathological examination is useful in some disorders. Diagnosing the disorders is important, because the underlying causes may be treatable, and some of the disorders are associated with malignancies and life-threatening systemic involvement. In this review, I present a concise, systematic approach to the treatment of the patient with reticulate hyperpigmentation. © The Author(s). CED
© 2011 British Association of Dermatologists.

Entities:  

Mesh:

Year:  2011        PMID: 21671993     DOI: 10.1111/j.1365-2230.2011.04100.x

Source DB:  PubMed          Journal:  Clin Exp Dermatol        ISSN: 0307-6938            Impact factor:   3.470


  4 in total

Review 1.  Cutaneous Manifestations of Scleroderma and Scleroderma-Like Disorders: a Comprehensive Review.

Authors:  Caterina Ferreli; Giulia Gasparini; Aurora Parodi; Emanuele Cozzani; Franco Rongioletti; Laura Atzori
Journal:  Clin Rev Allergy Immunol       Date:  2017-12       Impact factor: 8.667

Review 2.  The etiology and molecular genetics of human pigmentation disorders.

Authors:  Laura L Baxter; William J Pavan
Journal:  Wiley Interdiscip Rev Dev Biol       Date:  2012-05-17       Impact factor: 5.814

3.  A Novel Locus for Ectodermal Dysplasia of Hair, Nail and Skin Pigmentation Anomalies Maps to Chromosome 18p11.32-p11.31.

Authors:  Rabia Habib; Muhammad Ansar; Manuel Mattheisen; Muhammad Shahid; Ghazanfar Ali; Wasim Ahmad; Regina C Betz
Journal:  PLoS One       Date:  2015-06-26       Impact factor: 3.240

Review 4.  Reticulate hyperpigmentation in systemic sclerosis: a case report and review of the literature.

Authors:  Mati Chuamanochan; Andrea L Haws; Penvadee Pattanaprichakul
Journal:  J Med Case Rep       Date:  2015-09-28
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.